Timken director granted 2,270 deferred shares
TIMKEN CO director Kimberly K. Ryan received an equity award in the form of common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
TIMKEN CO director Kimberly K. Ryan received an equity award in the form of common stock. On May 2, the company reported the vesting of 2,270 time-based restricted share units that were originally granted on May 2, 2025. Following this award, Ryan is credited with 2,270 common shares. She elected to defer receipt of these shares under the company’s deferred compensation plan for directors, so this is a compensation-related, non-market acquisition rather than an open-market purchase.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 2,270 | $0.00 | $0.00 |
Footnotes (2)
- F1. Represents vesting of 100% of the time-based restricted share units granted on May 2, 2025.
- F2. The reporting person has elected to defer the receipt of such shares until a later date under the issuer's deferred compensation plan for directors.
Key Figures
Key Terms
deferred compensation plan financial
Grant, award, or other acquisition financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did TIMKEN CO (TKR) report for Kimberly K. Ryan?
What do the footnotes in Kimberly K. Ryan’s TIMKEN CO (TKR) Form 4 explain?
Is Kimberly K. Ryan’s TIMKEN CO (TKR) Form 4 transaction a market signal?
AI-generated analysis. How Rhea-AI works. Not financial advice.